期刊
ONCOTARGET
卷 7, 期 40, 页码 65888-65901出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.11676
关键词
cancer stem cells; glioblastoma; genetic alterations; drug discovery; primary cell culture
资金
- 'Miguel Servet Program' from Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain [CP11/00147, PI-01495, PI12/00775]
- FEDER
- Ministerio de Economia y Competitividad, Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD12/0036/0027]
- [PI10/01069]
- [PI14/00077]
Human gliomas harbour cancer stem cells (CSCs) that evolve along the course of the disease, forming highly heterogeneous subpopulations within the tumour mass. These cells possess self-renewal properties and appear to contribute to tumour initiation, metastasis and resistance to therapy. CSC cultures isolated from surgical samples are considered the best preclinical in vitro model for primary human gliomas. However, it is not yet well characterized to which extent their biological and functional properties change during in vitro passaging in the serum-free culture conditions. Here, we demonstrate that our CSC-enriched cultures harboured from one to several CSC clones from the human glioma sample. When xenotransplanted into mouse brain, these cells generated tumours that reproduced at least three different dissemination patterns found in original tumours. Along the passages in culture, CSCs displayed increased expression of stem cell markers, different ratios of chromosomal instability events, and a varied response to drug treatment. Our findings highlight the need for better characterization of CSC-enriched cultures in the context of their evolution in vitro, in order to uncover their full potential as preclinical models in the studies aimed at identifying molecular biomarkers and developing new therapeutic approaches of human gliomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据